Logo image of MUX

MCEWEN INC (MUX) Stock Fundamental Analysis

USA - NYSE:MUX - US58039P3055 - Common Stock

20.25 USD
+0.43 (+2.17%)
Last: 10/23/2025, 8:19:24 PM
20.33 USD
+0.08 (+0.4%)
After Hours: 10/23/2025, 8:19:24 PM
Fundamental Rating

3

MUX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 155 industry peers in the Metals & Mining industry. Both the profitability and financial health of MUX have multiple concerns. While showing a medium growth rate, MUX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MUX has reported negative net income.
MUX had a positive operating cash flow in the past year.
MUX had negative earnings in 4 of the past 5 years.
MUX had negative operating cash flow in 4 of the past 5 years.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

MUX's Return On Assets of -1.84% is in line compared to the rest of the industry. MUX outperforms 50.32% of its industry peers.
MUX has a Return On Equity of -2.80%. This is comparable to the rest of the industry: MUX outperforms 51.61% of its industry peers.
Industry RankSector Rank
ROA -1.84%
ROE -2.8%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

MUX has a Gross Margin of 21.71%. This is in the better half of the industry: MUX outperforms 61.29% of its industry peers.
MUX's Gross Margin has improved in the last couple of years.
MUX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MUX has been increased compared to 1 year ago.
The number of shares outstanding for MUX has been increased compared to 5 years ago.
Compared to 1 year ago, MUX has an improved debt to assets ratio.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MUX has an Altman-Z score of 0.37. This is a bad value and indicates that MUX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MUX (0.37) is worse than 86.45% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that MUX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.26, MUX is doing worse than 61.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC8.29%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MUX has a Current Ratio of 2.35. This indicates that MUX is financially healthy and has no problem in meeting its short term obligations.
MUX has a Current ratio (2.35) which is in line with its industry peers.
MUX has a Quick Ratio of 1.82. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.82, MUX is in line with its industry, outperforming 55.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.82
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.16% over the past year.
The Revenue has decreased by -9.48% in the past year.
Measured over the past years, MUX shows a quite strong growth in Revenue. The Revenue has been growing by 8.32% on average per year.
EPS 1Y (TTM)70.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.08%
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-1.63%

3.2 Future

Based on estimates for the next years, MUX will show a very strong growth in Earnings Per Share. The EPS will grow by 91.01% on average per year.
MUX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.62% yearly.
EPS Next Y119.96%
EPS Next 2Y71.76%
EPS Next 3Y91.01%
EPS Next 5YN/A
Revenue Next Year-15.65%
Revenue Next 2Y-4.77%
Revenue Next 3Y27.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MUX is valuated quite expensively with a Price/Forward Earnings ratio of 34.37.
MUX's Price/Forward Earnings ratio is in line with the industry average.
MUX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.33, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 34.37
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

MUX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.96
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MUX's earnings are expected to grow with 91.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.76%
EPS Next 3Y91.01%

More info and screens

0

5. Dividend

5.1 Amount

MUX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MCEWEN INC

NYSE:MUX (10/23/2025, 8:19:24 PM)

After market: 20.33 +0.08 (+0.4%)

20.25

+0.43 (+2.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03
Inst Owners43.82%
Inst Owner Change0%
Ins Owners0.55%
Ins Owner Change0.81%
Market Cap1.10B
Revenue(TTM)168.17M
Net Income(TTM)-13543000
Analysts80
Price Target15.81 (-21.93%)
Short Float %13.48%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)245.37%
Min EPS beat(2)-3.31%
Max EPS beat(2)494.06%
EPS beat(4)2
Avg EPS beat(4)89.43%
Min EPS beat(4)-197.03%
Max EPS beat(4)494.06%
EPS beat(8)4
Avg EPS beat(8)27.58%
EPS beat(12)6
Avg EPS beat(12)-30.55%
EPS beat(16)6
Avg EPS beat(16)-98.99%
Revenue beat(2)0
Avg Revenue beat(2)-7.62%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)-5.74%
Revenue beat(4)2
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)6.45%
Revenue beat(8)6
Avg Revenue beat(8)1.93%
Revenue beat(12)6
Avg Revenue beat(12)-3.64%
Revenue beat(16)6
Avg Revenue beat(16)-4.58%
PT rev (1m)1.22%
PT rev (3m)2.9%
EPS NQ rev (1m)113.33%
EPS NQ rev (3m)18.52%
EPS NY rev (1m)0%
EPS NY rev (3m)48.48%
Revenue NQ rev (1m)9.78%
Revenue NQ rev (3m)4.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.37
P/S 6.52
P/FCF N/A
P/OCF 53.42
P/B 2.26
P/tB 2.26
EV/EBITDA 46.96
EPS(TTM)-0.37
EYN/A
EPS(NY)0.59
Fwd EY2.91%
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)0.38
OCFY1.87%
SpS3.11
BVpS8.95
TBVpS8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.84%
ROE -2.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.71%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 5.31
Cap/Depr 201.64%
Cap/Sales 34.53%
Interest Coverage N/A
Cash Conversion 86.56%
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 1.82
Altman-Z 0.37
F-Score5
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.08%
EPS Next Y119.96%
EPS Next 2Y71.76%
EPS Next 3Y91.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-1.63%
Revenue Next Year-15.65%
Revenue Next 2Y-4.77%
Revenue Next 3Y27.62%
Revenue Next 5YN/A
EBIT growth 1Y82.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.29%
EBIT Next 3Y101.59%
EBIT Next 5YN/A
FCF growth 1Y66.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.17%
OCF growth 3YN/A
OCF growth 5YN/A